HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hirofumi Makino Selected Research

Anemia

4/2011Management of anemia in chronic kidney disease patients: baseline findings from Chronic Kidney Disease Japan Cohort Study.
12/2004The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
8/2003Pelvic lymphocyst infection associated with maternally inherited diabetes mellitus.
3/2003Perturbation of autocrine/paracrine loops of burst-forming units of erythroid-derived cells in rHuEPO-hyporesponsive hemodialysis patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hirofumi Makino Research Topics

Disease

73Diabetic Nephropathies (Diabetic Nephropathy)
11/2022 - 01/2002
38Type 2 Diabetes Mellitus (MODY)
11/2023 - 07/2003
30Albuminuria
12/2021 - 07/2004
29Vasculitis (Vasculitides)
06/2023 - 08/2008
28Proteinuria
11/2023 - 04/2002
27Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
11/2023 - 06/2012
24Chronic Kidney Failure (Chronic Renal Failure)
01/2022 - 01/2002
23Inflammation (Inflammations)
01/2021 - 10/2002
19Hypertension (High Blood Pressure)
01/2020 - 10/2002
17Glomerulonephritis
03/2023 - 11/2002
17Hypertrophy
01/2015 - 10/2003
16Fibrosis (Cirrhosis)
11/2023 - 02/2001
16Body Weight (Weight, Body)
01/2022 - 02/2003
15Chronic Renal Insufficiency
11/2022 - 01/2004
14Microscopic Polyangiitis
11/2023 - 12/2009
14Rheumatoid Arthritis
11/2015 - 01/2004
12Obesity
11/2015 - 04/2005
11Hyperglycemia
01/2016 - 07/2003
11Insulin Resistance
01/2013 - 10/2002
10Atherosclerosis
01/2013 - 01/2002
10Nephrotic Syndrome (Syndrome, Nephrotic)
12/2012 - 01/2002
10IGA Glomerulonephritis (IGA Nephropathy)
12/2012 - 04/2002
9Edema (Dropsy)
12/2021 - 01/2002
8Renal Insufficiency (Renal Failure)
02/2024 - 09/2006
8Heart Failure
11/2022 - 05/2014
8Nephritis
01/2017 - 11/2002
8Diabetes Mellitus
01/2016 - 04/2002
8Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2013 - 06/2005
7Interstitial Lung Diseases (Interstitial Lung Disease)
12/2023 - 10/2011
7Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
01/2021 - 12/2014
7Neoplasms (Cancer)
01/2017 - 07/2003
6Lupus Nephritis
02/2024 - 07/2003
6Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 12/2005
6Pituitary Neoplasms (Pituitary Adenoma)
02/2012 - 07/2003
5Atrophy
11/2023 - 06/2004
5Kidney Diseases (Kidney Disease)
10/2018 - 01/2012
5Acute Kidney Injury (Acute Renal Failure)
12/2015 - 01/2002
5Wounds and Injuries (Trauma)
01/2013 - 11/2005
5Peripheral Arterial Disease
10/2012 - 11/2003
5Acatalasia (Acatalasemia)
12/2011 - 06/2004
4Stroke (Strokes)
01/2020 - 01/2010
4Weight Gain
01/2018 - 02/2004
4Infections
07/2017 - 09/2008
4Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2016 - 07/2003
4Anemia
04/2011 - 03/2003

Drug/Important Bio-Agent (IBA)

37Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
06/2023 - 08/2008
32CreatinineIBA
11/2023 - 08/2005
30AlbuminsIBA
11/2022 - 10/2003
18CytokinesIBA
01/2016 - 10/2002
16Glucose (Dextrose)FDA LinkGeneric
01/2017 - 01/2002
14AtrasentanIBA
11/2022 - 05/2014
14Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 11/2003
14Proteins (Proteins, Gene)FDA Link
01/2017 - 01/2005
13Biomarkers (Surrogate Marker)IBA
01/2021 - 08/2004
13Angiotensin IIIBA
12/2011 - 02/2001
12Peroxidase (Myeloperoxidase)IBA
12/2023 - 03/2012
11Hemoglobins (Hemoglobin)IBA
11/2023 - 11/2008
11GlucocorticoidsIBA
11/2023 - 04/2002
11Blood Glucose (Blood Sugar)IBA
01/2016 - 06/2003
9Immunoglobulin A (IgA)IBA
01/2020 - 11/2003
9Collagen Type IV (Type IV Collagen)IBA
01/2015 - 01/2002
9Streptozocin (Streptozotocin)FDA Link
01/2014 - 02/2003
8C-Reactive ProteinIBA
01/2021 - 06/2003
8Angiotensin Receptor AntagonistsIBA
12/2015 - 07/2003
8Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
12/2015 - 01/2002
8Messenger RNA (mRNA)IBA
11/2015 - 07/2003
8Telmisartan (Micardis)FDA Link
01/2013 - 08/2004
8Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
08/2011 - 07/2003
7Antigen-Antibody Complex (Immune Complex)IBA
01/2020 - 11/2003
7Insulin (Novolin)FDA Link
01/2016 - 10/2002
7Therapeutic UsesIBA
01/2015 - 11/2002
7Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
10/2012 - 02/2004
6Endothelin Receptor AntagonistsIBA
11/2022 - 05/2014
6LigandsIBA
03/2013 - 01/2002
6AdipokinesIBA
02/2013 - 07/2005
6Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2005 - 01/2004
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2022 - 06/2012
5Adrenal Cortex Hormones (Corticosteroids)IBA
11/2022 - 01/2004
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2014 - 06/2003
5Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2014 - 03/2011
5SteroidsIBA
12/2013 - 01/2002
5CatalaseIBA
03/2012 - 06/2004
5Angiogenesis InhibitorsIBA
04/2011 - 07/2004
4Prednisolone (Predate)FDA LinkGeneric
01/2021 - 08/2009
4CholesterolIBA
01/2019 - 12/2011
4Uric Acid (Urate)IBA
12/2018 - 02/2008
4olmesartanIBA
03/2016 - 09/2006
4ChemokinesIBA
03/2013 - 06/2005
4Losartan (Cozaar)FDA LinkGeneric
03/2013 - 07/2006
4Advanced Glycation End ProductsIBA
02/2013 - 10/2003
4Pioglitazone (Actos)FDA Link
04/2012 - 07/2005
4SaltsIBA
03/2012 - 03/2003
4Transforming Growth Factors (Transforming Growth Factor)IBA
01/2012 - 10/2003
4AdiponectinIBA
01/2012 - 07/2005
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2010 - 11/2003

Therapy/Procedure

51Therapeutics
02/2024 - 01/2002
10Remission Induction
03/2023 - 06/2012
10Renal Dialysis (Hemodialysis)
04/2014 - 01/2002
4Kidney Transplantation
11/2019 - 09/2006
4Peritoneal Dialysis
11/2012 - 01/2008